APA (7th ed.) Citation

Brümmendorf, T. H., Ersöz, I., Hartmann, U., Balabanov, S., Wolke, H., Paschka, P., . . . Hochhaus, A. (2003). Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia. Annals of the New York Academy of Sciences, 996, . https://doi.org/10.1111/j.1749-6632.2003.tb03229.x

Chicago Style (17th ed.) Citation

Brümmendorf, Tim Henrik, et al. "Normalization of Previously Shortened Telomere Length Under Treatment with Imatinib Argues Against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia." Annals of the New York Academy of Sciences 996 (2003). https://doi.org/10.1111/j.1749-6632.2003.tb03229.x.

MLA (9th ed.) Citation

Brümmendorf, Tim Henrik, et al. "Normalization of Previously Shortened Telomere Length Under Treatment with Imatinib Argues Against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia." Annals of the New York Academy of Sciences, vol. 996, 2003, https://doi.org/10.1111/j.1749-6632.2003.tb03229.x.